Stockreport

X4 Pharmaceuticals To Present Research Data At The 2022 European Hematology Association (EHA) Congress Supporting Mechanism And Market Potential For Mavorixafor [TheStreet.com]

X4 Pharmaceuticals, Inc.  (XFOR) 
Last x4 pharmaceuticals, inc. earnings: 3/12 07:30 am Check Earnings Report
PDF BOSTON, May 16, 2022 (GLOBE NEWSWIRE) -- (Nasdaq: XFOR), a leader in the discovery and development of novel CXCR4-targeted small molecule therapeutics to benefit people [Read more]